rs765948340
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001099922.3(ALG13):c.751-8_751-6del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000906 in 1,147,559 control chromosomes in the GnomAD database, including 2 homozygotes. There are 19 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000071 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000093 ( 2 hom. 19 hem. )
Consequence
ALG13
NM_001099922.3 splice_polypyrimidine_tract, intron
NM_001099922.3 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.90
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant X-111708952-CTCT-C is Benign according to our data. Variant chrX-111708952-CTCT-C is described in ClinVar as [Likely_benign]. Clinvar id is 412615.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0000715 (8/111964) while in subpopulation EAS AF= 0.000839 (3/3576). AF 95% confidence interval is 0.000228. There are 0 homozygotes in gnomad4. There are 0 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG13 | NM_001099922.3 | c.751-8_751-6del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000394780.8 | NP_001093392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG13 | ENST00000394780.8 | c.751-8_751-6del | splice_polypyrimidine_tract_variant, intron_variant | 2 | NM_001099922.3 | ENSP00000378260 | A2 | |||
ALG13-AS1 | ENST00000430794.1 | n.106+2041_106+2043del | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000715 AC: 8AN: 111964Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34164
GnomAD3 genomes
AF:
AC:
8
AN:
111964
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34164
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000744 AC: 10AN: 134319Hom.: 1 AF XY: 0.0000499 AC XY: 2AN XY: 40065
GnomAD3 exomes
AF:
AC:
10
AN:
134319
Hom.:
AF XY:
AC XY:
2
AN XY:
40065
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000927 AC: 96AN: 1035595Hom.: 2 AF XY: 0.0000597 AC XY: 19AN XY: 318299
GnomAD4 exome
AF:
AC:
96
AN:
1035595
Hom.:
AF XY:
AC XY:
19
AN XY:
318299
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000715 AC: 8AN: 111964Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34164
GnomAD4 genome
AF:
AC:
8
AN:
111964
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34164
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy, 36 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 11, 2020 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 15, 2023 | See Variant Classification Assertion Criteria. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at